Hepatocyte nuclear factor 4α suppresses the aggravation of colon carcinoma

Molecular Carcinogenesis

Volumn 55, Issue 5, 2016, Pages 458-472

  Yao, Hou Shan ^a   Wang, Juan ^a   Zhang, Xiao Ping ^b   Wang, Liang Zhe ^a   Wang, Yi ^a   Li, Xin Xing ^a   Jin, Kai Zhou ^a   Hu, Zhi Qian ^a   Wang, Wei Jun ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b TONGJI UNIVERSITY   (China)

Author keywords

Colon carcinoma; Epithelial mesenchymal transition; Hepatocyte nuclear factor 4 ; Wnt catenin signaling pathway

Indexed keywords

HEPATOCYTE NUCLEAR FACTOR 4ALPHA; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR TWIST; UVOMORULIN; VIMENTIN; BETA CATENIN; HEPATOCYTE NUCLEAR FACTOR 4; HNF4A PROTEIN, HUMAN;

ADULT; ARTICLE; CANCER STAGING; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; COLON CARCINOMA; CONTROLLED STUDY; DISEASE COURSE; DISTANT METASTASIS; DOWN REGULATION; ECTOPIC EXPRESSION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; SURVIVAL RATE; SURVIVAL TIME; TUMOR GROWTH; UPREGULATION; ANIMAL; APOPTOSIS; CANCER TRANSPLANTATION; CELL MOTION; COLON TUMOR; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION; GENETICS; HT 29 CELL LINE; METABOLISM; METASTASIS; MOUSE; PATHOLOGY; SURVIVAL ANALYSIS; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; BETA CATENIN; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLONIC NEOPLASMS; DISEASE PROGRESSION; DOWN-REGULATION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATOCYTE NUCLEAR FACTOR 4; HT29 CELLS; HUMANS; MALE; MICE; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; SURVIVAL ANALYSIS;

EID: 84926443835     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.22294     Document Type: Article

References (44)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. Rim SH, Seeff L, Ahmed F, King JB, Coughlin SS. Colorectal cancer incidence in the United States, 1999-2004: An updated analysis of data from the National Program of Cancer Registries and the Surveillance, Epidemiology, and End Results Program. Cancer 2009; 115: 1967-1976.
3. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759-767.
4. Rupnarain C, Dlamini Z, Naicker S, Bhoola K. Colon cancer: Genomics and apoptotic events. Biol Chem 2004; 385: 449-464.
5. Calvert PM, Frucht H. The genetics of colorectal cancer. Ann Intern Med 2002; 137: 603-612.
6. Sladek FM, Zhong WM, Lai E, Darnell JE, Jr. Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily. Genes Dev 1990; 4: 2353-2365.
7. Jiang S, Tanaka T, Iwanari H, et al. Expression and localization of P1 promoter-driven hepatocyte nuclear factor-4alpha (HNF4alpha) isoforms in human and rats. Nucl Recept 2003; 1: 5.
8. Babeu JP, Darsigny M, Lussier CR, Boudreau F. Hepatocyte nuclear factor 4alpha contributes to an intestinal epithelial phenotype in vitro and plays a partial role in mouse intestinal epithelium differentiation. Am Journal Physiol Gastrointest Liver Physiol 2009; 297: G124-G134.
9. Garrison WD, Battle MA, Yang C, Kaestner KH, Sladek FM, Duncan SA. Hepatocyte nuclear factor 4alpha is essential for embryonic development of the mouse colon. Gastroenterology 2006; 130: 1207-1220.
10. Frochot V, Alqub M, Cattin AL, et al. The transcription factor HNF-4alpha: A key factor of the intestinal uptake of fatty acids in mouse. Am Journal Physiol Gastrointest Liver Physiol 2012; 302: G1253-G1263.
11. Tirona RG, Lee W, Leake BF, et al. The orphan nuclear receptor HNF4alpha determines PXR- and CAR-mediated xenobiotic induction of CYP3A4. Nat Med 2003; 9: 220-224.
12. Satohisa S, Chiba H, Osanai M, et al. Behavior of tight-junction, adherens-junction and cell polarity proteins during HNF-4alpha-induced epithelial polarization. Exp Cell Res 2005; 310: 66-78.
13. Cattin AL, Le Beyec J, Barreau F, et al. Hepatocyte nuclear factor 4alpha, a key factor for homeostasis, cell architecture, and barrier function of the adult intestinal epithelium. Mol Cell Biol 2009; 29: 6294-6308.
14. Lazarevich NL, Shavochkina DA, Fleishman DI, et al. Deregulation of hepatocyte nuclear factor 4 (HNF4) as a marker of epithelial tumors progression. Exp Oncol 2010; 32: 167-171.
15. Tanaka T, Jiang S, Hotta H, et al. Dysregulated expression of P1 and P2 promoter-driven hepatocyte nuclear factor-4alpha in the pathogenesis of human cancer. J Pathol 2006; 208: 662-672.
16. Ning BF, Ding J, Yin C, et al. Hepatocyte nuclear factor 4 alpha suppresses the development of hepatocellular carcinoma. Cancer Res 2010; 70: 7640-7651.
17. Lucas B, Grigo K, Erdmann S, Lausen J, Klein-Hitpass L, Ryffel GU. HNF4alpha reduces proliferation of kidney cells and affects genes deregulated in renal cell carcinoma. Oncogene 2005; 24: 6418-6431.
18. Takano K, Hasegawa G, Jiang S, et al. Immunohistochemical staining for P1 and P2 promoter-driven hepatocyte nuclear factor-4alpha may complement mucin phenotype of differentiated-type early gastric carcinoma. Pathol Int 2009; 59: 462-470.
19. Ehehalt F, Rummele P, Kersting S, et al. Hepatocyte nuclear factor (HNF) 4alpha expression distinguishes ampullary cancer subtypes and prognosis after resection. Ann Surg 2011; 254: 302-310.
20. Oshima T, Kawasaki T, Ohashi R, et al. Downregulated P1 promoter-driven hepatocyte nuclear factor-4alpha expression in human colorectal carcinoma is a new prognostic factor against liver metastasis. Pathol Int 2007; 57: 82-90.
21. Boye K, Grotterod I, Aasheim HC, Hovig E, Maelandsmo GM. Activation of NF-kappaB by extracellular S100: Analysis of signal transduction mechanisms and identification of target genes. Int J Cancer 2008; 123: 1301-1310.
22. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002; 2: 442-454.
23. Yang M, Li SN, Anjum KM, et al. A double-negative feedback loop between Wnt-beta-catenin signaling and HNF4alpha regulates epithelial-mesenchymal transition in hepatocellular carcinoma. J Cell Sci 2013; 126: 5692-5703.
24. Lussier CR, Babeu JP, Auclair BA, Perreault N, Boudreau F. Hepatocyte nuclear factor-4alpha promotes differentiation of intestinal epithelial cells in a coculture system. Am J Physiol Gastrointest Liver Physiol 2008; 294: G418-G428.
25. Chiba H, Sakai N, Murata M, et al. The nuclear receptor hepatocyte nuclear factor 4alpha acts as a morphogen to induce the formation of microvilli. J Cell Biol 2006; 175: 971-980.
26. Darsigny M, Babeu JP, Dupuis AA, et al. Loss of hepatocyte-nuclear-factor-4alpha affects colonic ion transport and causes chronic inflammation resembling inflammatory bowel disease in mice. PLoS ONE 2009; 4: e7609.
27. Consortium UIG, Barrett JC, Lee JC, et al. Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region. Nat Genet 2009; 41: 1330-1334.
28. Marcil V, Sinnett D, Seidman E, et al. Association between genetic variants in the HNF4A gene and childhood-onset Crohn's disease. Genes Immun 2012; 13: 556-565.
29. Nieto MA. The ins and outs of the epithelial to mesenchymal transition in health and disease. Annu Rev Cell Dev Biol 2011; 27:347-376.
30. Teng Y, Zeisberg M, Kalluri R. Transcriptional regulation of epithelial-mesenchymal transition. J Clin Invest 2007; 117: 304-306.
31. Lee JM, Dedhar S, Kalluri R, Thompson EW. The epithelial-mesenchymal transition: New insights in signaling, development, and disease. J Cell Biol 2006; 172: 973-981.
32. Remo A, Pancione M, Zanella C, Vendraminelli R. Molecular pathology of colorectal carcinoma. A systematic review centred on the new role of the pathologist. Pathologica 2012; 104: 432-441.
33. Joyce T, Cantarella D, Isella C, Medico E, Pintzas A. A molecular signature for Epithelial to Mesenchymal transition in a human colon cancer cell system is revealed by large-scale microarray analysis. Clin Exp Metastasis 2009; 26: 569-587.
34. Yao D, Peng S, Dai C. The role of hepatocyte nuclear factor 4alpha in metastatic tumor formation of hepatocellular carcinoma and its close relationship with the mesenchymal-epithelial transition markers. BMC Cancer 2013; 13:432.
35. Pinto D, Clevers H. Wnt control of stem cells and differentiation in the intestinal epithelium. Exp Cell Res 2005; 306: 357-363.
36. Sancho E, Batlle E, Clevers H. Signaling pathways in intestinal development and cancer. Rev Cell Dev Biol 2004; 20:695-723.
37. Clevers H, Nusse R. Wnt/beta-catenin signaling and disease. Cell 2012; 149: 1192-1205.
38. Polakis P. Wnt signaling and cancer. Genes Dev 2000; 14: 1837-1851.
39. Anastas JN, Moon RT. WNT signalling pathways as therapeutic targets in cancer. Nat Rev Cancer 2013; 13: 11-26.
40. Luo J, Chen J, Deng ZL, et al. Wnt signaling and human diseases: What are the therapeutic implications?. Lab Invest 2007; 87: 97-103.
41. Segditsas S, Tomlinson I. Colorectal cancer and genetic alterations in the Wnt pathway. Oncogene 2006; 25: 7531-7537.
42. Gregorieff A, Clevers H. Wnt signaling in the intestinal epithelium: From endoderm to cancer. Genes Dev 2005; 19: 877-890.
43. Polette M, Mestdagt M, Bindels S, et al. Beta-catenin and ZO-1: Shuttle molecules involved in tumor invasion-associated epithelial-mesenchymal transition processes. Cells Tissues Organs 2007; 185: 61-65.
44. Schwartz B, lgamas-Dimantov AA, Hertz R, et al. Inhibition of colorectal cancer by targeting hepatocyte nuclear factor-4alpha. Int J Cancer 2009; 124: 1081-1089.